BUFD | GSEP | BUFD / GSEP | |
Gain YTD | 8.386 | 8.818 | 95% |
Net Assets | 1.5B | 393M | 382% |
Total Expense Ratio | 0.95 | 0.85 | 112% |
Turnover | 1.00 | 0.00 | - |
Yield | 0.00 | 0.00 | - |
Fund Existence | 5 years | 2 years | - |
BUFD | GSEP | |
---|---|---|
RSI ODDS (%) | 2 days ago53% | 2 days ago19% |
Stochastic ODDS (%) | 2 days ago47% | 2 days ago26% |
Momentum ODDS (%) | 2 days ago74% | 2 days ago68% |
MACD ODDS (%) | 2 days ago48% | 2 days ago38% |
TrendWeek ODDS (%) | 2 days ago69% | 2 days ago73% |
TrendMonth ODDS (%) | 2 days ago70% | 2 days ago71% |
Advances ODDS (%) | 4 days ago67% | 4 days ago71% |
Declines ODDS (%) | 10 days ago57% | 2 days ago43% |
BollingerBands ODDS (%) | 2 days ago54% | 2 days ago25% |
Aroon ODDS (%) | 2 days ago66% | 2 days ago69% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RICBX | 66.62 | 0.08 | +0.12% |
American Funds Invmt Co of Amer R2 | |||
SFENX | 11.44 | N/A | N/A |
Schwab Fundamental Emerging Mkts Eq Idx | |||
LIDFX | 9.91 | N/A | N/A |
Lord Abbett International Value F | |||
CRIAX | 11.24 | N/A | N/A |
CRM Small/Mid Cap Value Inst | |||
JFNCX | 60.98 | N/A | N/A |
Janus Henderson Global Life Sciences C |